02/2021 Advances were preceded by many failures Advances in the research and development of therapeutic options wi ... MORE →
02/2021 Treatment Outcomes There are significant differences in treatment outcomes across Eur ... MORE →
02/2021 The treatment of hematologic malignant diseases in Croatia has significantly improved Thanks to new knowledge and the discovery of new medicines that ha ... MORE →
02/2021 Advances were preceded by many failures Advances in the research and development of therapeutic options wi ... MORE →
02/2021 Treatment Outcomes There are significant differences in treatment outcomes across Eur ... MORE →
02/2021 The treatment of hematologic malignant diseases in Croatia has significantly improved Thanks to new knowledge and the discovery of new medicines that ha ... MORE →
02/2021 Cancer and COVID-19: “A Tightrope Walk” Cancer patients are dying from coronavirus – and many will bear ... MORE →
02/2021 Time for joint action – EFPIA WAIT indicator The annual survey titled “EFPIA Patients WAIT”, conducted by t ... MORE →
02/2021 Principles of the European Cancer Dashboard: integrating stakeholders in oncology health policies European organizations involved in oncology health policies have c ... MORE →
02/2021 Lung Cancer – Croatia Can and Should Do Better Lung cancer in Europe kills almost as many people as breast, color ... MORE →
02/2021 Remember, even during the COVID-19 pandemic, people still develop cancer Almost forty years ago, the first bone marrow transplant was perfo ... MORE →
02/2021 Comparative Report on Cancer in Europe The Comparative Report on Cancer in Europe provides an overview of ... MORE →
10/2018 The future has arrived – medicines that are transforming treatment approaches At the end of August and the beginning of September, the U.S. Food ... MORE →
08/2017 iF! position on biological and biosimilar medicines Therapy switch means a medical practice in which the physician dec ... MORE →
07/2017 Position of the Innovative Pharmaceutical Industry on the Public Procurement Act If price were to continue accounting for 90% of the selection crit ... MORE →
03/2017 EFPIA #WeWontRest Illness never sleeps. Neither do we. EFPIA #WeWontRest promo video ... MORE →
04/2016 EFPIA/iF! Code on Disclosure of Data 2016 Transparency, trust, and understanding of relationships focused on ... MORE →
07/2015 Support the transparency of relationships The public is interested in the nature of the relationship between ... MORE →
02/2015 EFPIA/iF! Code on Data Disclosure – 10 Key Messages Collaboration between the pharmaceutical industry and healthcare p ... MORE →
02/2015 EFPIA/iF! Code on Publication of Data EFPIA/iF! believes that collaboration between the pharmaceutical i ... MORE →
04/2014 EFPIA Disclosure Code video EFPIA believes that interactions between the pharmaceutical indust ... MORE →
03/2014 iF! is the new name of CARPC iF! signifies a commitment to innovation, both in innovative medic ... MORE →
09/2013 iF!’s Position on the Role of the Pharmaceutical Industry in the Continuing Medical Education of Physicians Physician education is an ongoing process that does not end with t ... MORE →
02/2021 Advances were preceded by many failures Advances in the research and development of therapeutic options wi ... MORE →
02/2021 Treatment Outcomes There are significant differences in treatment outcomes across Eur ... MORE →
02/2021 The treatment of hematologic malignant diseases in Croatia has significantly improved Thanks to new knowledge and the discovery of new medicines that ha ... MORE →
02/2021 Advances were preceded by many failures Advances in the research and development of therapeutic options wi ... MORE →
02/2021 Treatment Outcomes There are significant differences in treatment outcomes across Eur ... MORE →
02/2021 The treatment of hematologic malignant diseases in Croatia has significantly improved Thanks to new knowledge and the discovery of new medicines that ha ... MORE →
02/2021 Cancer and COVID-19: “A Tightrope Walk” Cancer patients are dying from coronavirus – and many will bear ... MORE →
02/2021 Time for joint action – EFPIA WAIT indicator The annual survey titled “EFPIA Patients WAIT”, conducted by t ... MORE →
02/2021 Principles of the European Cancer Dashboard: integrating stakeholders in oncology health policies European organizations involved in oncology health policies have c ... MORE →
02/2021 Lung Cancer – Croatia Can and Should Do Better Lung cancer in Europe kills almost as many people as breast, color ... MORE →
02/2021 Remember, even during the COVID-19 pandemic, people still develop cancer Almost forty years ago, the first bone marrow transplant was perfo ... MORE →
02/2021 Comparative Report on Cancer in Europe The Comparative Report on Cancer in Europe provides an overview of ... MORE →
10/2018 The future has arrived – medicines that are transforming treatment approaches At the end of August and the beginning of September, the U.S. Food ... MORE →
08/2017 iF! position on biological and biosimilar medicines Therapy switch means a medical practice in which the physician dec ... MORE →
07/2017 Position of the Innovative Pharmaceutical Industry on the Public Procurement Act If price were to continue accounting for 90% of the selection crit ... MORE →
03/2017 EFPIA #WeWontRest Illness never sleeps. Neither do we. EFPIA #WeWontRest promo video ... MORE →
04/2016 EFPIA/iF! Code on Disclosure of Data 2016 Transparency, trust, and understanding of relationships focused on ... MORE →
07/2015 Support the transparency of relationships The public is interested in the nature of the relationship between ... MORE →
02/2015 EFPIA/iF! Code on Data Disclosure – 10 Key Messages Collaboration between the pharmaceutical industry and healthcare p ... MORE →
02/2015 EFPIA/iF! Code on Publication of Data EFPIA/iF! believes that collaboration between the pharmaceutical i ... MORE →
04/2014 EFPIA Disclosure Code video EFPIA believes that interactions between the pharmaceutical indust ... MORE →
03/2014 iF! is the new name of CARPC iF! signifies a commitment to innovation, both in innovative medic ... MORE →
09/2013 iF!’s Position on the Role of the Pharmaceutical Industry in the Continuing Medical Education of Physicians Physician education is an ongoing process that does not end with t ... MORE →
